Showing results (2341-2350 of 2,434) with videos related to

Sort By:
Pageof 244
European Review for Medical and Pharmacological Sciences|December 30, 2020
Risk factors of COVID-19 mortality: a systematic review of current literature and lessons from recent retracted articlesK H Lee, J S Kim, S H Hong, et al.
Physical Review Letters|July 16, 2013
Dynamics of low-intermediate-high-confinement transitions in toroidal plasmasJ Cheng, J Q Dong, K Itoh, et al.
Physical Review Letters|September 26, 2012
Frequency-resolved nonlinear turbulent energy transfer into zonal flows in strongly heated L-mode plasmas in the HL-2A tokamakM Xu, G R Tynan, P H Diamond, et al.
ESMO Open|January 1, 2022
Pembrolizumab versus chemotherapy for patients with esophageal squamous cell carcinoma enrolled in the randomized KEYNOTE-181 trial in AsiaY Cao, S Qin, S Luo, et al.
Physical Review Letters|September 28, 2010
Observation of a spontaneous particle-transport barrier in the HL-2A tokamakW W Xiao, X L Zou, X T Ding, et al.
The Journal of Experimental Medicine|May 20, 2025
A multimorphic variant in ThPOK causes an inborn error of immunity with T cell defects and fibrosisMaryam Vaseghi-Shanjani, Mehul Sharma, Pariya Yousefi, et al.
Cancer Research|December 17, 2008
Wnt5A regulates expression of tumor-associated antigens in melanoma via changes in signal transducers and activators of transcription 3 phosphorylationSamudra K Dissanayake, Purevdorj B Olkhanud, Michael P O'Connell, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|July 12, 2018
[Efficacy and safety of paritaprevir/ritonavir/ombitasvir combined with dasabuvir in non-cirrhotic Asian adult patients with newly diagnosed and treated chronic HCV genotype 1b infection: a randomized, double-blind, placebo-controlled study - China data]L Wei, J Cheng, J Luo, et al.
Leukemia|January 19, 2017
Genetics of ancestry-specific risk for relapse in acute lymphoblastic leukemiaS E Karol, E Larsen, C Cheng, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2022
Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancerK Van Baelen, T Geukens, M Maetens, et al.
Pageof 244